Srs Capital Advisors, Inc. Novo Cure LTD Transaction History
Srs Capital Advisors, Inc.
- $1.5 Billion
- Q4 2024
A detailed history of Srs Capital Advisors, Inc. transactions in Novo Cure LTD stock. As of the latest transaction made, Srs Capital Advisors, Inc. holds 933 shares of NVCR stock, worth $21,393. This represents 0.0% of its overall portfolio holdings.
Number of Shares
933
Previous 1,208
22.76%
Holding current value
$21,393
Previous $18,000
50.0%
% of portfolio
0.0%
Previous 0.0%
Shares
3 transactions
Others Institutions Holding NVCR
# of Institutions
266Shares Held
76.7MCall Options Held
1.17MPut Options Held
318K-
Black Rock Inc. New York, NY12.1MShares$278 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA11.8MShares$272 Million0.0% of portfolio
-
Capital International Investors Los Angeles, CA7.92MShares$182 Million0.02% of portfolio
-
Capital World Investors Los Angeles, CA4.31MShares$98.8 Million0.01% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD2.81MShares$64.3 Million0.03% of portfolio
About NovoCure Ltd
- Ticker NVCR
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Instruments & Supplies
- Shares Outstandng 104,950,000
- Market Cap $2.41B
- Description
- NovoCure Limited, an oncology company, engages in the development, manufacture, and commercialization of tumor treating fields (TTFields) devices for the treatment of solid tumor cancers in the United States, Europe, the Middle East, Africa, Japan, and Greater China. Its TTFields devices include Optune for the treatment of glioblastoma; and Optu...